Biosergen AB OMXSTO:BIOSGN:
SAID ON FRIDAY FLERIE AND BIOSERGEN HAVE AGREED ON A MERGER PLAN - FLERIE'S FIRST NEW INVESTMENT SINCE ITS LISTING ON NASDAQ STOCKHOLM
TO BE ABSORBED BY FLERIE; OPERATIONS TO NEW FLERIE INVEST AB SUBSIDIARY
RIGHTS ISSUE OF UP TO 79.84 MILLION SHARES AT SEK 0.5 PER SHARE FULLY COVERED
VALUED AT SEK 0.67 PER SHARE, 33% PREMIUM TO RIGHTS ISSUE PRICE
TO RECEIVE AT LEAST SEK 39.9 MILLION FROM RIGHTS ISSUE BEFORE ISSUE COSTS